UP

Pfizer has withdrawn a drug at risk for cancer

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Pfizer has dropped the anti-cancer drug Chantix due to the risk of cancer.

Axar.az reports this step was taken due to the high content of cancer-causing substances in the pills.

Experts from the Food and Drug Administration of the US Department of Health and Human Services have come to this conclusion.

Studies show that long-term use of the drug increases the risk of cancer.

Date
2021.09.19 / 18:31
Author
Axar.az
See also

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

WHO pushes bold reforms, launching 3 by 35 initiative

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla